Logo Drug Research

Together breaking new ground in drug research

The Helmholtz Drug Research Initiative builds on an exquisite joint technology infrastructure of the participating Helmholtz health centres and their partners, established and upgraded by major investments in instrumentation, technology and personnel through Portfolio funding. On this basis an increased stream of highly qualified drug candidates shall flow by

  • guided access to the most advanced and appropriate resources and expertise, guaranteeing an optimal multi-centre support of projects from idea to successful translation, without gap
  • an expanding joint knowledge base to continuously improve understanding of complex pathologies and the development of intelligent approaches for treatments
  • cross-centre technology sharing through training of staff and students
  • scientific and strategic outreach to the academic and industrial world through a series of workshops and conferences presenting the progress of the work
  • integration into global networks and knowledge communities to secure cutting–edge research

News

  • 10. January 2020

    HDDC 2020: 3rd Helmholtz Drug Discovery Conference

    Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and scientists from biotech and pharmaceutical industries. With topics focusing on anti-infectives, innovative screens, novel targets and target validation, computational approaches incl. artificial intelligence (AI) and more, this event will be an excellent opportunity to discuss the challenges and chances of modern drug discovery in academia and industry.

    more information

Do you have questions?